Optimization of an HPLC-PDA analytical method for therapeutic monitoring of oral busulfan in hematopoietic stem cell transplant patients. RSD [Internet]. 2021 Jun. 7 [cited 2025 Dec. 5];10(6):e48110615864. Available from: https://www.rsdjournal.org/rsd/article/view/15864